Wednesday, August 6, 2014

Monsanto in bed with DOD over Ebola can't be good

http://www.examiner.com/article/monsanto-bed-with-dod-over-ebola-can-t-be-good
Monday, Fox news reported that "The experimental drug used to treat two American aid workers who have been infected with the Ebola virus has never been tested on humans before and was only identified earlier this year as part of an ongoing research program backed by the U.S. government and military."
Fox also said, "The Defense Department has long had a hand in researching infectious diseases, including Ebola. During much of the Cold War period this served two purposes: to keep abreast of diseases that could limit the effectiveness of troops deployed abroad and to be prepared if biological agents were used as weapons." It was also stated that the U.S. military currently has no biological weapons program.
But not to worry, a new player has entered the ring. It seems that Monsanto and the DOD have teamed up to invest in an Ebola virus treatment company. Monsanto, the company that has given us Agent Orange, Roundup pesticide, and GMO food, is now working to give us an Ebola vaccine. What is Monsanto's gain one must ask. The deal is, the seed money Monsanto will contribute begins at $1.5 million. The value of the deal has the potential to grow to an estimated $86 million dollars. The company’s name is Tekmira Pharmaceuticals Corporation (TKMR) (TKM.TO), a leading developer of RNA interference (RNAi) therapeutics. “TKM-Ebola, an anti-Ebola virus RNAi therapeutic, is being developed under a $140 million contract with the U.S. Department of Defense’s Medical Countermeasure Systems BioDefense Therapeutics (MCS-BDTX) Joint Product Management Office”. That's a pretty sweet deal by anyone's calculations.
READ MORE: http://www.examiner.com/article/monsanto-bed-with-dod-over-ebola-can-t-be-good

No comments:

Post a Comment